Table 1.
ID | Module Function % | Top 5 Genes | Type | Differential Expression P-value | Enrichment of Putative Causal Genes, P-value | Module Ranking | ||||
---|---|---|---|---|---|---|---|---|---|---|
BP$ | MD$ | SZ$ | BP$ | MD$ | SZ$ | |||||
3 | neuronal system; synaptic transmission; gated channel activity | SPHKAP, GABRA6, NEUROD1, CADPS2, CNTN6 | Causal | 0.23 | 0.42 | 0.49 | 4.E-12 | 2.E-07 | 1.E-12 | 34 |
13 | axon guidance; nervous system development; glutamate receptor activity | DLK1, ZIC1, PTN, GNAL, DNER | Causal & DE | 0.14 | 0.13 | 3.E-05 | 7.E-11 | 8.E-11 | 8.E-04 | 33 |
10 | neuronal system; nervous system development; glutamate receptor activity | PMP2, SLC22A3, SLC17A8, KAL1, CHL1 | Causal | 0.90 | 0.72 | 0.09 | 2.E-07 | 7.E-11 | 5.E-06 | 42 |
4 | neuronal system; nervous system development; voltage gated cation channel activity | RGS4, TESPA1, GDA, HTR2A, CDH9 | Causal | 0.61 | 0.10 | 0.18 | 7.E-04 | 2.E-10 | 4.E-06 | 41 |
23 | GPCR downstream signaling; transmission of nerve impulse; receptor activity | RELN, MET, PENK, CALB1, GCNT4 | Causal & DE | 2.E-04 | 0.83 | 8.E-04 | 4.E-05 | 1.E-07 | 1.E-07 | 37 |
38 | HIF1 TF pathway; signal transduction; drug binding | FKBP5, SLC14A1, PDK4, IL1RL1, ZBTB16 | DE | 9.E-03 | 0.14 | 3.E-08 | 0.05 | 0.35 | 0.26 | 13 |
6 | oxidative phosphorylation; carbohydrate metabolic process; oxidoreductase activity | GSTT1, LAPTM4B, ATP6AP1, ATP6V0B, PITHD1 | DE | 2.E-03 | 0.25 | 1.E-03 | 0.21 | 0.62 | 0.43 | 7 |
28 | cell cycle; cell cycle process; taste receptor activity | PI15, DLEU1, MSTN, FKBP14, SYCP2L | DE | 2.E-05 | 0.79 | 0.24 | 0.20 | 0.87 | 0.66 | 4 |
For each module, three functional terms are provided. They are the most significant terms in canonical pathways, gene ontology (GO) biological process, and GO molecular functions.
BP: bipolar disorder; MD: major depression; SZ: schizophrenia.